OriGen Biomedical

OriGen Biomedical is a well-established, privately-held manufacturer providing essential tools for the cell and gene therapy industry. Its core business revolves around cryopreservation systems, cell culture bags, and ancillary solutions that are critical for the storage, transport, and processing of cellular therapies and biological materials. The company maintains ISO 13485 and MDSAP certifications, underscoring its commitment to quality in regulated manufacturing environments. With a strong operational history since 2000 and recognition as a top workplace, OriGen is positioned as a trusted supplier in the rapidly growing advanced therapies market.

Portfolio of specialized medical devices for biopreservation and cell culture, including cryopreservation bags with protective overwrap (O-Wrap®), high-purity DMSO solutions (CryoPur®), cell culture bags, and sterile fluid transfer accessories. Focus on material science, closed-system design, and cGMP manufacturing for the cell therapy supply chain.

Operates in a competitive landscape dominated by large players like Cytiva (Danaher), Thermo Fisher Scientific, Sartorius, and MilliporeSigma, who offer broad portfolios of bioprocess equipment and consumables. OriGen differentiates through specialization in cryopreservation, deep technical expertise, agility in custom development, and a strong focus on product quality and reliability for critical cell handling steps.